Pregnant women who were near the 9/11 attacks in New York don’t have to worry that they might have put their unborn child at risk from exposure to toxic dust.
Even cigarette companies say women shouldn’t use snus or smoke cigarettes while pregnant — but some just find it impossible to stop. Like this woman who wrote a heart-wrenching account of her addiction after taking up smoking at age 14:
More news from Scandinavia: the smokeless tobacco product “snus”, when used by pregnant women, is associated with a slight increase in the rate of stillbirths as compared to women who used no tobacco, a survey of 611,000 Swedish women has found.
Mammograms: Not so beneficial after all?
A less-aggressive type of surgery to treat early stage breast cancer is just as effective as the standard, more extensive treatment, according to a new study.
Activist groups yesterday urged an FDA advisory committee to recommend mandatory labels for Aquabounty’s genetically-engineered Atlantic salmon, to distinguish it from conventional salmon.
Teresa Heinz clearly hasn’t read Lawrence Meyer’s anti-alarmist blog post against baseless chemical scares — her foundation has deemed the dubious BPA research of University of Missouri biological sciences professor Frederick vom Saal worthy of the $100,000
ACSH staffers offer a seat at the ACSH Dispatch table to journalist Lawrence Meyers for speaking out against the alarmist cosmetic scares spread by Siobhan O Connor and Alexandra Sprunt, authors of the book No More Dirty Looks: The Truth About Your Beauty Products and the Ultimate
ACSH’s Dr. Josh Bloom yesterday participated in a webinar whose ostensible aim was a discussion of the efficacy of taxing sugary beverages as a weapon in the fight against obesity. But rather than discussing the pros and cons of such a tax, participants focused mostly on generating revenue through taxes on soda and sweetened juice.
Boehringer Ingelheim’s Spiriva — a drug approved for emphysema and chronic lung conditions — was shown to be just as effective as GlaxoSmithKline’s asthma drug Serevent and more effective than a double dose of inhaled steroids, according to new research published in the New England Journal of Medicine.
